By prolonging time to intracranial progression without causing deterioration in neurocognition or quality of life, TTFields therapy following SRS is a new treatment option for patients with non-small ...

Even in the case of resectable disease status, the prognosis for pancreatic cancer remains poor. Evidence from multiple ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has found that women with ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

On October 8, 2025, the US FDA approved the immunotherapy cemiplimab-rwlc (Libtayo) for adjuvant treatment of adult patients ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high local cure rates in the management of non-melanoma skin cancer.

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

Knee osteoarthritis is a degenerative joint disease causing pain, swelling and stiffness in the knees that worsens over time.

In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...